VolitionRx Fully Repays $7.5M Convertible Note Ahead of Schedule
VolitionRx Limited (NYSE AMERICAN: VNRX) has fully repaid a senior secured convertible promissory note in the amount of $7,500,000 to Lind Global Asset Management XII LLC ahead of its scheduled maturity date. The prepayment was made more than eight months early and eliminates potential equity dilution for shareholders associated with this debt obligation. The company still has an outstanding senior secured convertible promissory note from January 7, 2026, in the amount of $2,400,000. CEO Cameron Reynolds emphasized that prepaying the first note is part of a broader strategy to strengthen Volition's financial position and reduce debt while prioritizing shareholder value. Volition remains focused on developing epigenetics-based blood tests for early disease detection and monitoring, including cancers and conditions related to NETosis such as sepsis.